Topics in Gastrointestinal Cancer

Boston, MA US
February 1, 2020

Description

Novel treatment options for gastrointestinal cancers and the introduction of biomarkers have resulted in considerable improvements in patient outcomes but have also increased the complexity of treatment decisions for practicing clinicians. This annual CME symposium led by Dana-Farber/Brigham and Women’s Cancer Center and Massachusetts General Hospital Cancer Center will provide attendees with the latest information on managing and treating gastrointestinal cancers, including biliary, colorectal, and pancreatic, neuroendocrine tumors, and the genomics of gastrointestinal cancers. Through lecture, panel discussion, and Q&A, this course is designed to help practitioners integrate this knowledge into their own daily practice.

Target Audience

This educational activity is designed for: medical and radiation oncologists, colon and rectal surgeons, gastroenterologists, primary care physicians, nurse practitioners, and other interested clinicians involved in the care of patients with GI cancers.

Learning Objectives

Upon completion of this course, attendees will be able to:

  1. Evaluate new surgical approaches for upper gastrointestinal malignancies and apply these procedures in routine clinical practice.
  2. Assess new management and treatment options for pancreatic, biliary and neuroendocrine tumors, and utilize these approaches in routine clinical practice to benefit patients.
  3. Appraise targeted therapy options for patients with colorectal cancer.
  4. Evaluate the role of inherited genetics through case studies and outline how to interpret and use genomics in clinical practice.
  5. Appraise and evaluate emerging approaches to radiation therapy in gastrointestinal malignancies.
  6. Interpolate and discuss the management of gastrointestinal cancers across a multidisciplinary treatment team including advanced practice profiders.

 

About the Gastrointestinal Cancer Centers of Dana-Farber/Brigham and Women’s Cancer Center and Massachusetts General Hospital Cancer Center


We offer comprehensive care for patients with gastrointestinal cancers, including cancers of the colon, rectum, stomach, esophagus, pancreas, anus, bile duct (cholangiocarcinoma), liver, gallbladder, and small bowel, as well as carcinoid and islet cell malignancies.  At each cancer center, care is provided by a multidisciplinary team that includes medical oncologists; radiation oncologists; colorectal, gastrointestinal, and oncologic surgeons; and gastroenterologists, with consultative support from gastrointestinal pathologists and gastrointestinal diagnostic and interventional radiologists.

These Harvard Medical School-affiliated centers provide the latest therapies in surgery, chemotherapy, and radiation for gastrointestinal cancers.  Both centers also have active clinical research programs exploring new drug treatments and multimodality therapies.  Genetic counseling, molecular diagnostic testing, and support services, including social work, nutrition counseling, and educational and support groups are also offered.

Additional Information

Provided by: 

Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital Cancer Center and Partners HealthCare System

 

 

Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
  • 4.50 Nursing
  • 4.25 Participation
Course opens: 
11/12/2019
Course expires: 
03/01/2020
Event starts: 
02/01/2020 - 8:00am
Event ends: 
02/01/2020 - 2:00pm
Cost:
$75.00

Agenda

7:45 am

Registration Check-in and Continental Breakfast

8:15

Welcome and Introduction

Brian M. Wolpin, MD, MPH

8:20

Personalizing Therapy for Patients with Colorectal Cancer

Aparna R. Parikh, MD

8:50

Expanding Treatment Options in Neuroendocrine Tumors

Jennifer Chan, MD, MPH

9:20

New Approaches to Radiation for GI Malignancies

Harvey J. Mamon, MD, PhD

9:50

Pancreatic Cancer: Progress in Evaluation and Therapy

Brian M. Wolpin, MD, MPH

10:20

Break

10:45

Biliary Cancer: New Therapies for New Targets

Lipika Goyal, MD

11:15

Surgical Advances for Upper GI Malignancies

Jiping Wang, MD, PhD

11:45

Interpretation and Use of Genomics in Clinical Practice

Jonathan A. Nowak, MD, PhD and Marios Giannakis, MD, PhD

12:15 pm

Case Presentations from the Audience*

Moderator: Brian M. Wolpin, MD, MPH

Panelists: All presenters and Michael Casey, NP

*Participants will be encouraged to present their own problem cases for discussion by the panel and are encouraged to bring case materials.

12:50

Concluding Remarks

Brian M. Wolpin, MD, MPH

1:00 pm

Adjourn

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lunch will be served at 1:00 pm

Four Seasons Hotel
200 Boylston
Boston, MA 02116
United States

This course will be held at the Four Seasons Hotel, 200 Boylston Street, Boston MA 02116.  For directions, click here

Linking URL: http://www.fourseasons.com/boston/destination/directions_and_maps/

Brian M. Wolpin, MD, MPH; Course Director


Director, Gastrointestinal Cancer Center,
Robert T. and Judith B. Hale Chair in Pancreatic Cancer,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor of Medicine,
Harvard Medical School


Michael Casey, APRN-BC, FNP

Nurse Practitioner, Gastrointestinal Cancer Center,
Dana-Farber/Brigham and Women’s Cancer Center 


Jennifer Chan, MD, MPH

Director, Program in Carcinoid and Neuroendocrine Tumors,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School


Marios Giannakis, MD, PhD

Medical Oncologist, Gastrointestinal Cancer Center,
Dana-Farber/Brigham and Women’s Cancer Center;
Assistant Professor of Medicine,
Harvard Medical School


Lipika Goyal, MD

Medical Oncologist, Division of Hematology/Oncology,
Massachusetts General Hospital Cancer Center;
Instructor in Medicine,
Harvard Medical School


Harvey J. Mamon, MD, PhD

Chief, Division of Gastrointestinal Radiation Oncology,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor, Radiation Oncology,
Harvard Medical School


Jonathan A. Nowak, MD, PhD

Pathologist,
Brigham and Women’s Hospital;
Assistant Professor, Pathology,
Harvard Medical School


Aparna R. Parikh, MD

Medical Oncologist, Division of Hematology/Oncology,
Massachusetts General Hospital;
Instructor in Medicine,
Harvard Medical School


Jiping Wang, MD, PhD

Surgical Oncologist, Gastrointestinal Cancer Center,
Dana-Farber/Brigham and Women’s Cancer Center;
Associate Professor, Surgery,
Harvard Medical School

Partners HealthCare System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Partners HealthCare System designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Nursing Credits

Dana-Farber Cancer Institute is an approved provider of continuing nursing education by the American Nurses Association Massachusetts, an accredited approver by the American Nurses’ Credentialing Center’s Commission on Accreditation.

4.5 nursing contact hours will be awarded for attending the event in its entirety and completion of an evaluation.

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
  • 4.50 Nursing
  • 4.25 Participation

Accreditation Period

Course opens: 
11/12/2019
Course expires: 
03/01/2020

Price

Cost:
$75.00
Please login or register to take this course.

Registration Fee: non-refundable and includes course materials, continental breakfast, and lunch

  • Early Bird Rate: $75.00 through January 20, 2020
  • Regular Rate: $85.00 after January 20, 2020

 

For questions regarding registration, please contact the Partners Office of Continuing Professional Development at partnerscpd@partners.org or 857-282-2513.

For questions regarding the conference, please call 800-553-3787.

If you have any food allergies, or if you require accommodations such as an ASL interpreter, materials in an alternative format, or wheelchair access, please contact our course coordinator 10 days prior to the event at kwooten@partners.org or call 1-800-553-3787.

Required Hardware/software

The EthosCE standard install will support the two most recent stable releases of the following browsers for all public pages, both authenticated users and anonymous: Internet Explorer, Edge, Firefox, Google Chrome, Safari, Firefox. EthosCE supports these browsers by default. Other browsers may work also; however, non-listed browsers are not officially supported.